Synovus Financial Corp Novo Nordisk A S Transaction History

Synovus Financial Corp

$8.56 Billion
Q3 2024

A detailed history of Synovus Financial Corp transactions in Novo Nordisk A S stock. As of the latest transaction made, Synovus Financial Corp holds 54,697 shares of NVO stock, worth $4.78 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

54,697

Previous 54,697 -0.0%

Holding current value

$4.78 Million

Previous $6.51 Million -0.0%

% of portfolio

0.08%

Previous 0.07%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$119.07 - $145.42 $319,583 - $390,307	2,684 Added 5.16%	54,697 $6.51 Million
Q2 2024 Aug 13, 2024	BUY	$122.71 - $146.91 $79,761 - $95,491	650 Added 1.27%	52,013 $7.42 Million
Q1 2024 May 14, 2024	BUY	$102.11 - $135.92 $228,420 - $304,053	2,237 Added 4.55%	51,363 $6.6 Million
Q3 2023 Nov 13, 2023	BUY	$90.94 - $199.54 $1.99 Million - $4.36 Million	21,873 Added 80.26%	49,126 $4.47 Million
Q2 2023 Aug 08, 2023	SELL	$155.98 - $172.65 $46,638 - $51,622	-299 Reduced 1.09%	27,253 $4.41 Million
Q1 2023 May 11, 2023	SELL	$132.34 - $159.14 $973,890 - $1.17 Million	-7,359 Reduced 21.08%	27,552 $4.38 Million
Q4 2022 Feb 06, 2023	SELL	$102.55 - $135.33 $316,366 - $417,493	-3,085 Reduced 8.12%	34,911 $4.72 Million
Q3 2022 Oct 27, 2022	SELL	$95.28 - $116.93 $375,974 - $461,405	-3,946 Reduced 9.41%	37,996 $3.79 Million
Q2 2022 Aug 10, 2022	SELL	$103.24 - $121.81 $689,436 - $813,447	-6,678 Reduced 13.74%	41,942 $4.68 Million
Q1 2022 May 12, 2022	SELL	$93.1 - $112.54 $96,824 - $117,041	-1,040 Reduced 2.09%	48,620 $5.4 Million
Q4 2021 Feb 14, 2022	SELL	$95.88 - $117.08 $444,307 - $542,548	-4,634 Reduced 8.54%	49,660 $5.56 Million
Q3 2021 Nov 08, 2021	BUY	$84.42 - $106.62 $302,645 - $382,232	3,585 Added 7.07%	54,294 $5.21 Million
Q2 2021 Aug 11, 2021	SELL	$67.66 - $84.76 $66,239 - $82,980	-979 Reduced 1.89%	50,709 $4.25 Million
Q1 2021 May 11, 2021	BUY	$67.06 - $75.82 $471,834 - $533,469	7,036 Added 15.76%	51,688 $3.49 Million
Q4 2020 Feb 11, 2021	BUY	$63.89 - $73.8 $134,616 - $155,496	2,107 Added 4.95%	44,652 $3.12 Million
Q3 2020 Nov 09, 2020	BUY	$63.69 - $70.22 $2.14 Million - $2.36 Million	33,630 Added 377.23%	42,545 $2.95 Million
Q2 2020 Aug 10, 2020	SELL	$58.54 - $67.94 $303,764 - $352,540	-5,189 Reduced 36.79%	8,915 $583,000
Q1 2020 Apr 24, 2020	BUY	$49.46 - $64.78 $317,533 - $415,887	6,420 Added 83.55%	14,104 $847,000
Q2 2019 Aug 08, 2019	SELL	$46.79 - $52.47 $2,667 - $2,990	-57 Reduced 0.74%	7,684 $392,000
Q1 2019 May 09, 2019	SELL	$46.36 - $52.63 $27,352 - $31,051	-590 Reduced 7.08%	7,741 $404,000
Q4 2018 Feb 07, 2019	BUY	$41.54 - $47.25 $7,352 - $8,363	177 Added 2.17%	8,331 $385,000
Q3 2018 Nov 01, 2018	BUY	$46.76 - $51.24 $71,963 - $78,858	1,539 Added 23.27%	8,154 $385,000
Q4 2017 Feb 09, 2018	SELL	$47.53 - $53.73 $81,181 - $91,770	-1,708 Reduced 20.52%	6,615 $355,000
Q3 2017 Nov 13, 2017	BUY	$41.15 - $49.22 $342,491 - $409,658	8,323	8,323 $401,000

Others Institutions Holding NVO

# of Institutions

1,957

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $197B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Synovus Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Synovus Financial Corp with notifications on news.

Account

Synovus Financial Corp Novo Nordisk A S Transaction History